Cholesterol Halved by CRISPR/Cas9 Base Editing – Genetic Engineering & Biotechnology News
R & D Magazine |
Cholesterol Halved by CRISPR/Cas9 Base Editing
Genetic Engineering & Biotechnology News Besides lowering the levels of triglycerides and low-density lipoprotein cholesterol in the blood, the mutation provides protection against coronary heart disease. These findings come from mouse research conducted by scientists based at the University … Gene-Editing Reduces Triglycerides, Cholesterol by Up to 50 Percent, Finds Penn Animal Study |
